Crisaborole 2% Topical Application Ointment [EUCRISA: Clinical Trials

1 trial of Crisaborole 2% Topical Application Ointment [EUCRISA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Crisaborole 2% Topical Application Ointment [EUCRISA: new trials by email Literature Review of Crisaborole 2% Topical Application Ointment [EUCRISA trials Research Report on Crisaborole 2% Topical Application Ointment [EUCRISA

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis
Crisaborole 2% Topical Application Ointment [EUCRISA, tacrolimus 0.1% - Atopic Dermatitis
Phase 4Not yet recruitingHayat Abad Medical Complex, Peshawar1482026-03-012026-03-02

Conditions studied

Dermatitis, Atopic (1)

Sponsors

Hayat Abad Medical Complex, Peshawar (1)

Countries

Pakistan (1)